When industry best practices or standards are not in place, life sciences enterprises with legacy content management systems confront many challenges, including inconsistent taxonomies and compliance risks. Complicated quality requirement definitions, configuration and validation processes, irregular naming protocols, patched together systems, and the use of non-validated tools add further complexities. How can life science enterprises harmonize their quality processes, improve their quality content management efficiency, and deliver innovative treatments to patients?
Life sciences enterprises can eliminate inconsistent content management practices inherent within legacy systems and lower compliance risks by adopting industry standards and best practices. Easy-to-use processes encourage adoption, and standards bring familiarity and a common language for content exchanges with contract partners - relationships that continue to become more critical in delivering innovation to patients. Besides, the industry is witnessing a positive shift as more enterprises adopt modern systems with built-in best practices and the capability to consolidate GxP and corporate governance. As a result, enterprises can move faster and more efficiently and are advancing quality management overall.
However, even before implementing a new system, enterprises can transform quality content management with greater alignment, streamlined processes, and improved efficiencies by modeling practices according to industry standards. In fact, the more these standards are applied across their value chains, the faster vital treatments will come to the market.
Click here to read the original article published by the European Pharmaceutical Manufacturer.
Please give your feedback on this article or share a similar story for publishing by clicking here.
